首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到18条相似文献,搜索用时 62 毫秒
1.
以取代靛红和肌氨酸为原料制得1,3-偶极子,再与(E)-芳姜烯酮类化合物在乙腈中经3+2环加成反应合成了10个新型的芳姜黄酮拼合吡咯螺环氧化吲哚类化合物(3a~3j)产率70%~91%, d/r值15 :1~>20:1,其结构经1H NMR, 13C NMR和HR-MS(ESI-TOF)表征。采用MTT法研究了3a~3j对人肺癌细胞(A549)和人白血病细胞(K562)的体外抗肿瘤活性。结果表明:3f对K562抑制活性较好(IC50=31.1 μmol·L-1), 3b对A549抑制活性较好(IC50=54.1 μmol·L-1)。  相似文献   

2.
以取代烷氧基嘧啶3-烯键氧化吲哚衍生物为原料,与肌氨酸及多聚甲醛在甲苯中回流经1,3-偶极子3+2环加成反应,合成了8个新型烷氧基嘧啶拼接3-吡咯螺环氧化吲哚类化合物(3a~3h),产率67%~82%,d/r值6/1~20/1,其结构经~1H NMR,~(13)C NMR和HR-MS(ESI-TOF)表征。采用MTT法研究了3a~3h对人肺癌细胞(A549)、人前列腺癌细胞(PC-3)和人白血病细胞(K562)的体外抗肿瘤活性。结果表明:3d和3g对人白血病细胞K562具有明显的活性,IC50分别为24.1 mol·L~(-1)和32.4μmol·L~(-1),接近阳性对照药顺铂。  相似文献   

3.
以硝基异噁唑-3-烯氧化吲哚1作为基于给体和受体的3C合成子,与叔丁基酯-3-烯氧化吲哚2,在碱性催化剂DABCO催化下发生Michael加成环化反应,获得10个新颖的连续双季碳螺环氧化吲哚拼接异噁唑类化合物3a~3j,产率为57%~70%, dr值为4/1~9/1, 其结构经1H NMR, 13C NMR和HR-MS(ESI-TOF)表征,并且经过单晶3f进一步确定了其结构。   相似文献   

4.
以3-异硫氰氧化吲哚与硝基异噁唑缩合的3-烯氧化吲哚,在二氯甲烷中无催化剂条件下于室温发生Michael加成环化反应,获得了8个未见文献报道的异噁唑拼接3,3′ 吡咯螺环双氧化吲哚类化合物(3a~3h),产率91%~95%,dr值5/3~3/1,其结构经1H NMR, 13C NMR和HR-MS(ESI-TOF)表征。  相似文献   

5.
以取代的3-羧酸活化色酮、靛红与消旋脯氨酸为原料,乙腈为溶剂,依次经1,3-偶极子[3+2]环加成和脱羧反应,合成了8个新型的二氢色原酮拼接多环吡咯螺环氧化吲哚类化合物 (3a~3h),产率68%~87%, dr值15/1~20/1,其结构经1H NMR, 13C NMR和HR-MS(ESI-TOF)表征。采用MTT法研究了3a~3h对人白血病细胞(K562)的体外抑制活性。结果表明:化合物3d,3f, 3g对K562具有一定的抑制活性(IC50=46.3~69.4 μmol·L-1)。  相似文献   

6.
卢玉  黎峥  田民义  刘雄利  张敏 《合成化学》2021,21(5):406-411
以色酮-氧化吲哚C3合成子1与硝基异噁唑苯乙烯2为原料,在相转移催化剂碱性作用下,依次发生γ-位区域选择性Michael加成,分子内Michael加成环化反应,合成了8个新颖的异噁唑色满酮拼接螺环氧化吲哚类化合物3a~3h,产率42%~58%,dr值>20/1, 其结构经1H NMR, 13C NMR和HR-MS(ESI-TOF)表征。采用MTT法研究了3a~3h对人白血病细胞(K562)的体外抗增殖活性。结果表明:化合物3b, 3d, 3f和3g对K562增殖具有一定的抑制活性。   相似文献   

7.
潘博文  韩晓雪  石洋  田又平  刘雄利 《合成化学》2021,29(12):1026-1032
以硝基异噁唑苯乙烯与靛红衍生的三氟甲基亚胺为原料,在有机碱三乙胺的催化作用下,发生Michael加成环化反应,得到了12个未见文献报道的异噁唑-三氟甲基螺环氧化吲哚类化合物3a~3l,产率73%~89%,dr值10/1~>20/1, 其结构经1H NMR, 13C NMR和HR-MS(ESI-TOF)表征,通过单晶进一步进行了确定化合物3e的相对构型。该类化合物含有连续4个立体中心,其中包含一个螺环季碳中心。采用MTT法研究了3a~3l对人白血病细胞(K562)的体外抗肿瘤活性。结果表明:化合物3c,3d,3h和3i对K562具有一定的抑制活性, 说明异噁唑-三氟甲基螺环氧化吲哚骨架可以作为抗肿瘤先导化合物进一步研究。  相似文献   

8.
以靛红衍生的三氟甲基亚胺与硝基异噁唑苯乙烯为原料,在有机碱DABCO催化作用下,发生[3+2]环加成反应,获得合成了15个新颖的异噁唑拼接三氟甲基螺环吡咯氧化吲哚类化合物3a~3o,产率71%~90%,dr值>20/1, 其结构经1H NMR, 13C NMR和HR-MS(ESI-TOF)表征,化合物3f的相对构型通过单晶进一步进行了确定。该类化合物含有连续4个立体中心,包括一个螺环季碳中心。   相似文献   

9.
新型异噁唑啉类化合物的合成及其抗肿瘤活性   总被引:1,自引:0,他引:1  
刘冰妮  刘默  刘登科  刘巍  祁浩飞 《合成化学》2011,19(6):734-736,761
以3,4-二氟苯甲醛为起始物,经4步反应合成了关键中间体N-[{3-[3-氟-4-(1-哌嗪基)苯基]4,5-二氢-5-异噁唑}甲基]乙酰胺(4);4与取代苯磺酰氯经亲核取代反应合成了6个新型的异噁唑啉类化合物(6a~6f),其结构经1H NMR和MS表征.采用MTT法对6a~6f进行初步生物活性测试结果表明,部分化合...  相似文献   

10.
本文以色酮-氧化吲哚合成子(1)与硝基异噁唑苯乙烯(2),催化剂DBU作用下,经分子间Michael加成,分子内Michael加成环化反应,获得7个新型异噁唑山酮素骨架螺环氧化吲哚类化合物3a~3g,产率87%~93%,dr=8/1~15/1, 其结构经1H NMR, 13C NMR和HR-MS(ESI-TOF)表征。   相似文献   

11.
A facile synthesis of novel dispiro oxindole-pyrrolothiazole-androsterone hybrid heterocycles has been achieved through 1,3-dipolar cycloaddition. The reaction proceeds stereo- and regioselectively, affording a single isomer of the product in excellent yields with the formation of two C–C and one C–N bonds and creation of four new contiguous stereocenters in one step.  相似文献   

12.
Aliphatic and aromatic nitro compounds were selectively reduced to their corresponding amino derivatives in good yields using formic acid and raney nickel. This system is found to be compatible with several sensitive functionalities such as halogens, -OH, -OCH3, -CHO, -COCH3, -COC6H5, -COOH, -COOC2H5, -CONH2, -CN, -CH=CH-COOH, -NHCOCH3. The reduction can be carrid out not only with HCOOH but also with HCOONH4.  相似文献   

13.
The 1,3-dipolar cycloaddition of azomethine ylides generated in situ from the reaction of acenaphthylene-1,2-dione or isatins and α-amino acids to (E)-methyl/ethyl 2-(3-oxo-3,4-dihydro-2H-benzo[b][1,4]thiazin-2-ylidene)acetate led to the stereoselective formation of novel dispiro 1,4-benzothiazine hybrid heterocycles in good yields.  相似文献   

14.
Synthesis of a series of spirooxindolonitro pyrrolizidines and spiroindanonitro pyrrolizidines has been accomplished. The nonstabilized azomethine ylides generated from isatin and ninhydrin with proline reacted with nitro styrenes to regioselectively yield spirocycloadducts.  相似文献   

15.
Spirocyclic compounds isolated from plant and animal origins have important applications in medicinal chemistry. Spiro compounds having cyclic structures fused at a central carbon are of recent interest because of their interesting conformational features and their structural implications for biological systems. Spiro heterocycles like spiropyrrolidines and oxindole moieties have been found to play fundamental roles in biological processes and have exhibited diversified biological activity and pharmacological and therapeutical properties. In view of these facts we decided to present a representative synthetic scheme and various biological activities of the heterocycles like spiropyrrolidines and oxindole moieties derivatives, especially in relation to microbial infections like cancer and tubercular, viral, HIV, bacterial, and fungal infections.  相似文献   

16.
潘华  徐亮 《合成化学》2012,20(4):466-469
N-三甲基硅甲基苄胺和多聚甲醛在磷酸催化下生成非稳定型亚甲胺基叶立德,继而与各种贫电子烯烃在温和条件下发生三组分1,3-偶极环加成反应,高收率合成了10个3,4-二取代四氢吡咯衍生物(其中6个为新化合物),其结构经1H NMR,13C NMR和HR-MS表征。  相似文献   

17.
The solid-phase synthesis of pyrrolidine and pyrrole derivatives using polymer-supported α-silylimines is described. Polymer-supported azomethine ylides were generated from the corresponding α-silylimine by thermal 1,2-silatropy onto the imino nitrogen or by treatment with a trifluorosilane as a quaternization and desilylation reagent, and the resulting species were then reacted with dipolarophiles to give five-membered heterocycles.  相似文献   

18.
The novel generation and cycloaddition of azomethine ylides from an α-(trimethylsilyl)imine using (polyfluoro)silanes is described. The method was successfully applied to an efficient one-pot process. Namely, an azaallyl anion, generated by abstraction of the hydrogen α to an imino nitrogen, was treated with a di- or trifluorosilane to give an azomethine ylide intermediate below room temperature. The generated 1,3-dipole was smoothly trapped with dipolarophiles to afford nitrogen-containing five-membered heterocycles in good yields.  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号